Lawrence D. Senour serves as Executive at HTG MOLECULAR DIAGNOSTICS, INC, where they oversee executive responsibilities. Since joining the company, Lawrence D. Senour has executed 8 insider transactions totaling $2.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 11, 2015 involved purchasing 167,343 shares valued at $2.3M.
Lawrence D. Senour currently holds 756,704 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence D. Senour has been a net buyer of HTGM stock. They have purchased $2.3M and sold $0 worth of shares.
Lawrence D. Senour's most recent insider trade was on May 11, 2015, when they purchased 167,343 shares at $14.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 90,494 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 192,373 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 70,898 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 1,963 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $775.3K | Other | 55,377 | $14.00 | Discretionary |
| May 11, 2015 | HTGM | $0 | Other | 52,929 | $N/A | Discretionary |